Tigecycline
تیژسیکلین
🦠 Antiinfectives For Systemic UseGlycylcycline
Market / country: 🇺🇸 USA
Tygacil (US)
🧮 Dose calculator
Complicated intra-abdominal infection and peritonitis · Regimen source: FDA Tygacil · 2.1
- • First dose 100 mg. Infuse over 30–60 min. Severe hepatic impairment: 100 then 25 mg every 12 h. Monitor fibrinogen and coagulation. FDA Tygacil · 2.1FDA Tygacil · 2.2FDA Tygacil · 2
Enter age (weight is optional for this regimen).
🛡️ Safety & information
Contraindications
- ⛔ Hypersensitivity to tigecycline. FDA Tygacil · 4
Warnings
- • Boxed warning: increased all-cause mortality — reserve for when alternatives are unsuitable. Children: only if no alternative. FDA Tygacil · Boxed WarningFDA Tygacil · 2.3
Formulations
- 50 mg vial — powder for injection 🇺🇸 USA FDA Tygacil · 3
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Tygacil · 8.1
“Risk Summary TYGACIL, like other tetracycline class antibacterial drugs, may cause permanent discoloration of deciduous teeth and reversible inhibition of bone growth when administered during the second and third trimesters of pregnancy [see Warnings and Precautions (5.7 , 5.8) , Data , and Use in Specific Populations …”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Tygacil · 8.2
“Risk Summary There are no data on the presence of tigecycline in human milk; however, tetracycline-class antibacterial drugs are present in breast milk.”
- 👶 ChildrenSafety not established
Label: safety and effectiveness in children have not been established. FDA Tygacil · 8.4
“Safety and effectiveness in pediatric patients below the age of 18 years have not been established.”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Tygacil · 8.5
“Of the total number of subjects who received TYGACIL in Phase 3 clinical studies (n=2514), 664 were 65 and over, while 288 were 75 and over.”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)NDA021821
- DailyMed (FDA label)FDA Tygacil
- MedlinePlus (NIH)Tigecycline Injection
- WHO ATC/DDDJ01AA12
- Darooyab (Iran)Tigecycline
🇮🇷 Registered in Iran Darooyab · G-5339/Tigecycline
Dosage forms with Iranian generic codes, per Darooyab.
- 23169 · TIGECYCLINE 50MG POWDER FOR INJ · فرآورده تزریقی تیجسایکلین ۵۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Tygacil · 3FDA Tygacil · 2.1FDA Tygacil · 2.2FDA Tygacil · 2FDA Tygacil · 4FDA Tygacil · Boxed WarningFDA Tygacil · 2.3FDA Tygacil · SPL approval / marketing categoryFDA Tygacil · 8.1FDA Tygacil · 8.2FDA Tygacil · 8.4FDA Tygacil · 8.5
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-5339/Tigecycline
- Clinical review⚠ Unverified